Get Our FREE Newsletter

Sign Up

Proteomics platform IsoPlexis files for a $100 million IPO

Spread the love

IsoPlexis, which provides a single cell proteomics platform for drug development, filed on Tuesday with the SEC to raise up to $100 million.IsoPlexis believes its platform, which includes instruments, chip consumables, and software, is the first to employ both proteomics and

This post was originally published on this site